All
What Makes a Quality Cancer Support Group?
After attending several cancer support groups, I reflect on what makes them helpful, inclusive and healing — and invite others to share their insights too.
How Personalized Cancer Vaccines Are Advancing Kidney Cancer Care
Personalized cancer vaccines may potentially represent a step forward in guiding the immune system to more precisely target kidney cancer.
Lung Cancer Study Links Treatment History to Quality-of-Life Differences
Quality-of-life in lung cancer varies, with certain treatments leading to sleep-related issues, pain, and emotional changes depending on disease stage.
Max The Butterfly: Hope and Resurrection After Cancer
Butterflies are believed to be a symbol of resurrection and hope. This is an inspiring story about this phenomenon.
FDA Votes Against Proposed Blenrep Treatment Combo’s for Multiple Myeloma
The FDA's Oncologic Drugs Advisory Committee has casted their votes on the utilization of certain treatments in the multiple myeloma patient population.
FDA Grants Priority Review to TAR-200 for Bladder Cancer Subset
FDA grants priority review to TAR-200, which demonstrated an 82% complete response in high-risk bladder cancer unresponsive to Bacillus Calmette-Guérin.
Ojjaara May Improve Anemia and Reduce Transfusions in Myelofibrosis
An expert highlights the impact of anemia in myelofibrosis and presented Ojjaara as a possible treatment to reduce transfusions and improve outcomes.
What’s in a Name? How I Chose ‘Person’ Over ‘Survivor’ After Cancer
When asked to choose a word other than “survivor” to describe myself, I chose “person” because cancer does not define who I am.
Regaining Independence After Ovarian Cancer Surgery
After ovarian cancer surgery, Mary Barbera spent three months in rehab before finally returning home, a milestone that marked her emotional recovery.
Enhertu Combo Receives FDA Designation in Metastatic HER2+ Breast Cancer
The FDA granted breakthrough therapy designation to first-line treatment with Enhertu plus Perjeta for unresectable or metastatic HER2+ breast cancer.
Writing Helped Me Heal After Pancreatic Cancer
Cancer leaves deep emotional scars long after treatment ends, but for many survivors, honest, unfiltered writing can be a powerful path to healing.
Key Skin Cancer Treatment Updates From 2025 and What is Still to Come
Dr. Ma discussed key findings that have been shared so far this year on the topic of evolving treatment strategies for patients with high-risk skin cancer.
FDA Grants Orphan Status to Liquid Glioma Treatment SH-110
SH-110, a liquid cancer treatment for glioma, earned orphan drug status from the FDA, helping patients who struggle to swallow pills access therapy.
Lung Cancer Survivor Shares What She Wishes She’d Known Sooner
Terry Gillespie said the hardest parts of her cancer journey were the isolation, the impact of chemotherapy, and how unprepared she felt.
Painting Passion During AML Recovery Sparked Lifelong Creative Joy
A watercolor set gifted during my bone marrow transplant for acute myeloid leukemia became my outlet for wonder, creativity, and lasting joy in recovery and beyond.
How Patients Can Find the Latest Breast Cancer Treatment Updates
Dr. Erika Hamilton says social media and professional guidelines help patients stay informed about fast-changing breast cancer treatments and advances.
Food Insecurity Linked to Higher Risk of Death After Cancer
Food insecurity is linked to a 28% higher risk of death among cancer survivors compared with those who have never received a cancer diagnosis, a new study found.
Breaking Down What CAR T-Cell Therapy Means for Blood Cancers
Dr. Olalekan O. Oluwole explained how CAR T is used to treat high-risk blood cancers and highlighted the potential of outpatient CAR T-cell therapy treatment.
The Magnificent Healing Power of Poetry for Those With Cancer
Writing poems following my lymphoma diagnosis gave me hope and purpose as I endured chemo, helping me heal and share my experience with others.
Carotuximab Combo Proves Safe for Advanced Prostate Cancer
Carotuximab plus Erleada proved safe in the first 10 patients with metastatic castration-resistant prostate cancer dosed on the phase 2 trial.
Outpatient CAR T-Cell Therapy May Be a Safe Option
Outpatient CAR T therapy has reduced hospital stays by two-thirds while maintaining safety for those with blood cancers, according to Dr. Olalekan Oluwole.
How Love Helped Me Face Leukemia and Keep Living
Facing leukemia and uncertainty, I leaned on love and resolve to keep living day by day, despite fear and an unknown future ahead.
How Biomarker Testing Can Inform Metastatic Breast Cancer Care
Dr. Masey Ross explains how biomarker testing, patient history, and quality-of-life concerns guide treatment decisions in metastatic breast cancer.
Coping With a Rare Cancer Diagnosis, Like GIST
Dr. Breelyn Wilky discusses challenges that patients with GIST face and shares advice with those who feel overwhelmed by the rarity of their condition.
Refining Treatment Approaches and Advancements in High-Risk Melanoma
Dr. Vincent Ma discussed the most recent and notable treatment updates for patients with high-risk and advanced melanoma.
Celebrating My Clean Bill of Health After Cancer
Laura Yeager is a two-time breast cancer survivor. Catch up on all of Laura's blogs here!
Bria-IMT Improves Survival in Patients With Metastatic Breast Cancer
Bria-IMT plus a checkpoint inhibitor improved survival versus Trodelvy and chemo in patients with heavily pretreated metastatic breast cancer.
How ADCs Are Redefining Chemotherapy in Breast Cancer Care
Dr. Paolo Tarantino shares how antibody-drug conjugates deliver more targeted chemo, and how the treatment lasts longer in the body vs traditional therapy.
Finding Freedom and Uncertainty in My Cancer Remission Pause
I’m in remission from small lymphocytic lymphoma and off treatment, savoring this break while learning to live with the uncertainty that still lingers.
Understanding Novel Therapy Utility in HER2+ Breast Cancer Treatment
Dr. Erika Hamilton discusses the most notable breast cancer treatments currently in development, and how might they change care for patients in the future.
